Data / New clinical trials / Atherosclerosis
Atherosclerosis trials: 139 new since Nov 2024
The full list. New Atherosclerosis clinical trials: 139 rows for $6.95, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/atherosclerosis, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
139 clinical studies in atherosclerosis were first posted on ClinicalTrials.gov from November 18, 2024 to November 5, 2026; 36 have an industry sponsor and 98 are recruiting or about to. The newest, NCT07920133, was posted on November 5, 2026: Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI... (Sir Run Run Shaw Hospital).
The request: Every new Atherosclerosis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 139New trials
- 36Industry sponsored
- 98Recruiting or not yet
- November 5, 2026Latest posted
Newest trials
The newest 100 of 139, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 5, 2026 | NCT07920133 | Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD) | Sir Run Run Shaw Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk | 1,768 | China | clinicaltrials.gov |
| November 4, 2026 | NCT07916883 | PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite) | Washington University School of Medicine | Observational | Not yet recruiting | Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis | 30 | United States | clinicaltrials.gov |
| November 4, 2026 | NCT07914777 | EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of... | NYU Langone Health | Not applicable | Not yet recruiting | Atherosclerotic Cardiovascular Disease | 7,501 | United States | clinicaltrials.gov |
| November 3, 2026 | NCT07913919 | Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study | University of Cambridge | Not applicable | Recruiting | Systemic Lupus Erythematosus, Atherosclerosis Generalized | 15 | United Kingdom | clinicaltrials.gov |
| October 30, 2026 | NCT07906132 | A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic... | Sanofi | Observational | Completed | Atherosclerotic Cardiovascular Disease | 93,000 | Italy | clinicaltrials.gov |
| October 29, 2026 | NCT07905534 | A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic... | Sanofi | Observational | Active not recruiting | Atherosclerotic Cardiovascular Disease | 18,000 | Spain | clinicaltrials.gov |
| October 29, 2026 | NCT07905508 | A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic... | Sanofi | Observational | Completed | Atherosclerotic Cardiovascular Disease | 180,000 | Netherlands | clinicaltrials.gov |
| October 16, 2026 | NCT07877324 | Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β | Turku University Hospital | Not applicable | Recruiting | Atheroscleroses, Inflammation | 90 | Finland | clinicaltrials.gov |
| October 8, 2026 | NCT07865884 | Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Observational | Not yet recruiting | Breast Cancer, Vascular Calcification, Coronary Artery Calcification, Atherosclerosis Cardiovascular Disease | 100 | clinicaltrials.gov | |
| October 2, 2026 | NCT07856264 | PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis | Fundación Santa Fe de Bogota | Observational | Not yet recruiting | Hyperlipidemia, Atherosclerotic Cardiovascular Disease (ASCVD) | 100 | clinicaltrials.gov | |
| October 2, 2026 | NCT07856199 | Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease | Hospital Central Militar | Not applicable | Recruiting | Coronary Artery Disease, Erectile Dysfunction, Atherosclerosis | 60 | Mexico | clinicaltrials.gov |
| September 30, 2026 | NCT07849127 | wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65 | Women's Heart Austria | Not applicable | Not yet recruiting | Cardiovascular Diseases (CVD), Coronary Artery Disease, Atheroscleroses | 800 | Austria | clinicaltrials.gov |
| September 25, 2026 | NCT07840950 | Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study | Xiangya Hospital of Central South University | Not applicable | Not yet recruiting | Carotid Artery Plaques, Atherosclerosis, Ischemic Stroke | 200 | clinicaltrials.gov | |
| September 24, 2026 | NCT07839936 | A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease | Verve Therapeutics, Inc. | Phase 2 | Not yet recruiting | Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia | 175 | United States | clinicaltrials.gov |
| September 24, 2026 | NCT07839741 | LDL Cholesterol Reduction Following Ezetimibe Initiation | Universidade do Porto | Phase 4 | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Risk, LDL Cholesterol | 100 | Portugal | clinicaltrials.gov |
| September 24, 2026 | NCT07837934 | Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes | Tan Tock Seng Hospital | Phase 2 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases | 300 | Singapore | clinicaltrials.gov |
| September 21, 2026 | NCT07832175 | AI-CCTA for Predicting Cardiovascular Events in CAD | Nanjing First Hospital, Nanjing Medical University | Observational | Active not recruiting | Coronary Artery Disease, Atherosclerotic Cardiovascular Disease | 3,000 | China | clinicaltrials.gov |
| September 2, 2026 | NCT07800481 | PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study) | Washington University School of Medicine | Early phase 1 | Recruiting | Healthy Adult, Healthy | 8 | United States | clinicaltrials.gov |
| September 2, 2026 | NCT07800351 | Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis | Tanta University | Phase 3 | Not yet recruiting | Rheumatoid Arthritis (RA, Atherosclerosis | 46 | Egypt | clinicaltrials.gov |
| August 25, 2026 | NCT07783802 | A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | 120 | Argentina, Japan, Puerto Rico, United States | clinicaltrials.gov |
| August 21, 2026 | NCT07780552 | CHIP in Health and Disease | VASCage GmbH | Observational | Not yet recruiting | Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance... | 120 | Austria | clinicaltrials.gov |
| August 20, 2026 | NCT07775664 | Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD Risk | Putuo Hospital, Shanghai University of Traditional Chinese Medicine | Not applicable | Active not recruiting | Type 2 Diabetes Mellitus, Endothelial Dysfunction, Cardiovascular Risk | 90 | China | clinicaltrials.gov |
| August 19, 2026 | NCT07772466 | Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media Thickness | Assiut University | Observational | Not yet recruiting | Atheroscleroses, Rheumatoid Arthritis (RA | 70 | clinicaltrials.gov | |
| August 14, 2026 | NCT07765797 | Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention | University Hospital, Toulouse | Observational | Not yet recruiting | Atheroscleroses, Geriatric | 290 | France | clinicaltrials.gov |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | Hungary | clinicaltrials.gov |
| July 27, 2026 | NCT07729475 | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of... | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Elevated Lipoprotein(a) | 120 | China | clinicaltrials.gov |
| July 22, 2026 | NCT07719894 | Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis | 1,200 | South Korea | clinicaltrials.gov |
| July 15, 2026 | NCT07704918 | Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma | University of Colorado, Denver | Not applicable | Recruiting | Melanoma | 40 | United States | clinicaltrials.gov |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 | clinicaltrials.gov | |
| July 15, 2026 | NCT07704164 | Colchicine to Reduce Coronary Artery Inflammation in People With HIV | Instituto de Investigación Hospital Universitario La Paz | Phase 2 | Recruiting | HIV Infection, Cardiovascular Diseases (CVD) | 90 | Spain | clinicaltrials.gov |
| July 9, 2026 | NCT07693712 | Senescence in Myocardial Infarction | South Tees Hospitals NHS Foundation Trust | Observational | Terminated | Cardiovascular Diseases, Coronary Artery Disease, Aging, Atherosclerosis, Myocardial Infarction, Inflammation, Heart... | 22 | United Kingdom | clinicaltrials.gov |
| July 7, 2026 | NCT07686991 | Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort Study | Groupe français d'étude des Maladies Inflammatoires de loeil | Observational | Completed | Takayasu Arteritis, Cardiovascular Diseases | 8,275 | France | clinicaltrials.gov |
| June 30, 2026 | NCT07675928 | Qatar Cardiometabolic Cohort | Weill Cornell Medical College in Qatar | Observational | Not yet recruiting | Cardiometabolic Diseases | 3,000 | Qatar | clinicaltrials.gov |
| June 24, 2026 | NCT07665034 | Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension | Chinese University of Hong Kong | Not applicable | Recruiting | Atherosclerosis Cardiovascular Disease | 200 | Hong Kong | clinicaltrials.gov |
| June 4, 2026 | NCT07625488 | Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3) | Radboud University Medical Center | Observational | Enrolling by invitation | Coronary Artery Disease, Atherosclerosis | 250 | Netherlands | clinicaltrials.gov |
| June 2, 2026 | NCT07619820 | A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) | CSL Behring | Phase 1 | Recruiting | End Stage Kidney Disease (ESKD) | 24 | China | clinicaltrials.gov |
| May 29, 2026 | NCT07615296 | Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and... | Beijing Anzhen Hospital | Not applicable | Not yet recruiting | Atherosclerotic Cardiovascular Disease (ASCVD) | 6,000 | China | clinicaltrials.gov |
| May 29, 2026 | NCT07615166 | Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine... | Sanofi | Observational | Completed | Atherosclerotic Cardiovascular Disease | 996 | United States | clinicaltrials.gov |
| May 29, 2026 | NCT07614230 | SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes | Junjie Yang | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis | 144 | China | clinicaltrials.gov |
| May 29, 2026 | NCT07613294 | A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High... | Eli Lilly and Company | Phase 3 | Recruiting | Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a) | 252 | Australia, Czechia, Hungary, Netherlands, Spain, United Kingdom, United States | clinicaltrials.gov |
| May 28, 2026 | NCT07611747 | Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) | Instituto de Investigación Marqués de Valdecilla | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular... | 1,944 | Spain | clinicaltrials.gov |
| May 18, 2026 | NCT07594392 | Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE | St. Jude Children's Research Hospital | Observational | Recruiting | Atherosclerotic Cardiovascular Disease | 650 | United States | clinicaltrials.gov |
| May 12, 2026 | NCT07581808 | Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention | University Medical Centre Ljubljana | Phase 4 | Recruiting | Hypercholesterolemia, Atherosclerotic Cardiovascular Disease (ASCVD) | 60 | Slovenia | clinicaltrials.gov |
| May 7, 2026 | NCT07573319 | The SCAPIS-Snus Study | Karolinska Institutet | Observational | Active not recruiting | Nicotine, Mental Health, Cardiovascular (CV) Risk, Metabolic Abnormalities | 30,154 | Sweden | clinicaltrials.gov |
| April 30, 2026 | NCT07558239 | Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors | Minia University | Observational | Not yet recruiting | Dialysis Patients, Hypertension, Atherosclerosis | 100 | clinicaltrials.gov | |
| April 29, 2026 | NCT07556887 | Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation | Maastricht University Medical Center | Not applicable | Recruiting | Carotid Artery Stenosis Symptomatic, Ischemic Cerebral Infarction, Stroke Ischemic, Atheroscleroses, Stroke (CVA) or... | 613 | Netherlands | clinicaltrials.gov |
| April 24, 2026 | NCT07551492 | A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 3 | Recruiting | Atherosclerotic Cardiovascular Disease | 9,262 | China | clinicaltrials.gov |
| April 22, 2026 | NCT07545408 | Subclinical Atherosclerosis in Juvenile Systemic Lupus Erythematosus | Assiut University | Observational | Not yet recruiting | Atherosclerosis | 70 | clinicaltrials.gov | |
| April 22, 2026 | NCT07543731 | A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab | Novartis Pharmaceuticals | Observational | Recruiting | Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia, Familial | 5,995 | Switzerland | clinicaltrials.gov |
| April 21, 2026 | NCT07542860 | Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients | Peking University First Hospital | Observational | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Secondary Prevention, Cardiovascular Diseases | 5,448 | China | clinicaltrials.gov |
| April 13, 2026 | NCT07524101 | Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD | Yonsei University | Not applicable | Recruiting | Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia, Cardiovascular Diseases | 1,952 | South Korea | clinicaltrials.gov |
| April 9, 2026 | NCT07521007 | A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis | Beijing Inno Medicine Co., Ltd. | Phase 2 | Recruiting | Atherosclerosis, Coronary Artery Disease | 456 | Australia, Canada, China, United States | clinicaltrials.gov |
| April 9, 2026 | NCT07520643 | MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Subclinical Atherosclerotic Cardiovascular Disease, Neurocognitive Decline | 1,000 | Italy | clinicaltrials.gov |
| March 25, 2026 | NCT07493603 | A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease | Xia Liang | Phase 1/2 | Recruiting | Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses | 30 | China | clinicaltrials.gov |
| March 23, 2026 | NCT07487363 | TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD | Hudson Biotech | Phase 1/2 | Recruiting | Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction | 80 | China | clinicaltrials.gov |
| March 16, 2026 | NCT07474233 | Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health | Liverpool John Moores University | Observational | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction | 90 | United Kingdom | clinicaltrials.gov |
| March 10, 2026 | NCT07462871 | Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health | Liverpool John Moores University | Not applicable | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia | 30 | United Kingdom | clinicaltrials.gov |
| March 10, 2026 | NCT07460960 | TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men | Lomonosov Moscow State University Medical Research and Educational Center | Phase 2 | Recruiting | Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen... | 150 | Russia | clinicaltrials.gov |
| March 4, 2026 | NCT07448038 | A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation... | Genentech, Inc. | Phase 2 | Recruiting | Atherosclerosis | 162 | Canada, United States | clinicaltrials.gov |
| March 3, 2026 | NCT07447648 | Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque... | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | Observational | Recruiting | Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography | 52 | France, Italy, Netherlands, Turkey (Türkiye) | clinicaltrials.gov |
| February 23, 2026 | NCT07428473 | A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) | Monash University | Phase 1 | Recruiting | Elevated LDL-C and High Cholesterol | 64 | Australia, New Zealand | clinicaltrials.gov |
| February 23, 2026 | NCT07427472 | "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)" | Assistance Publique - Hôpitaux de Paris | Not applicable | Recruiting | Heterozygous Familial Hypercholesterolemia (HeFH) | 300 | France | clinicaltrials.gov |
| February 19, 2026 | NCT07422051 | Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis | Spanish National Research Council | Phase 2 | Not yet recruiting | Atherosclerosis Cardiovascular Disease | 22 | Spain | clinicaltrials.gov |
| February 18, 2026 | NCT07416344 | A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China | Harbin Medical University | Not applicable | Enrolling by invitation | Coronary Artery Disease | 14,980 | China | clinicaltrials.gov |
| February 17, 2026 | NCT07412457 | Guideline Adherence in Dyslipidemia With Clinical Decision Support | I.M. Sechenov First Moscow State Medical University | Observational | Not yet recruiting | Dyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries, Cardiovascular Risk, Subclinical... | 500 | Russia | clinicaltrials.gov |
| February 9, 2026 | NCT07396025 | Effectiveness of Surgical and Diagnostic Methods in Cerebral Vascular Occlusive Disease | National Centre for Neurosurgery, Republic of Kazakhstan | Not applicable | Enrolling by invitation | Carotid Artery Occlusion | 60 | Kazakhstan | clinicaltrials.gov |
| February 6, 2026 | NCT07394400 | Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults. | Milagros Rocha Barajas | Observational | Not yet recruiting | Transgender Individuals | 94 | Spain | clinicaltrials.gov |
| February 3, 2026 | NCT07384910 | Assessment of GARP Expression in Acute and Chronic Coronary Syndrome | Université Catholique de Louvain | Not applicable | Not yet recruiting | Atheroma; Heart | 600 | Belgium | clinicaltrials.gov |
| February 2, 2026 | NCT07380828 | CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF) | Russian Scientific Medical Society of Therapists | Observational | Not yet recruiting | Heart Failure, Cardio-renal-metabolic Syndrome | 3,000 | clinicaltrials.gov | |
| January 23, 2026 | NCT07364058 | Assessment of Platelet-derived GARP in Atherosclerotic Disease | Université Catholique de Louvain | Observational | Not yet recruiting | Atheroma; Carotid Artery, Atheromatosis | 200 | Belgium | clinicaltrials.gov |
| January 21, 2026 | NCT07355894 | Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) | Stanford University | Not applicable | Not yet recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Artery Calcification | 120,000 | United States | clinicaltrials.gov |
| January 20, 2026 | NCT07352111 | High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Not applicable | Recruiting | Coronary Artery Diease | 200 | Italy | clinicaltrials.gov |
| January 12, 2026 | NCT07334834 | Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic... | Colorado Prevention Center | Not applicable | Recruiting | Hyperlipidemia | 100 | United States | clinicaltrials.gov |
| January 5, 2026 | NCT07315997 | The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study | Brigham and Women's Hospital | Observational | Recruiting | Rheumatoid Arthritis (RA, Atherosclerotic Cardiovascular Disease (ASCVD) | 120 | United States | clinicaltrials.gov |
| December 31, 2025 | NCT07312383 | Skin Microcirculation in Patients With Lower Limb Atherosclerosis | ODI Medical AS | Not applicable | Recruiting | Percutaneous Transluminal Angioplasty, Atherosclerosis of Arteries of the Extremities, Unspecified | 30 | Norway | clinicaltrials.gov |
| December 30, 2025 | NCT07311330 | Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction | Beijing Inno Medicine Co., Ltd. | Phase 2 | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction | 40 | China | clinicaltrials.gov |
| December 24, 2025 | NCT07301489 | Akershus Cardiac Examination (ACE) 5 Study | University Hospital, Akershus | Not applicable | Recruiting | Heavy Smokers, Lung Cancer Screening, Cardiovascular Risk Profile, Cardiovascular Disease Prevention | 1,000 | Norway | clinicaltrials.gov |
| December 22, 2025 | NCT07296965 | Oral Microbiome in Carotid Atherosclerosis | Semmelweis University Heart and Vascular Center | Observational | Recruiting | Atherosclerosis Cardiovascular Disease, Atherosclerosis of Artery, Carotid Artery Plaque, Periodontitis, Carotid Artery... | 200 | Hungary | clinicaltrials.gov |
| December 19, 2025 | NCT07295366 | Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial | The Affiliated Hospital of Xuzhou Medical University | Phase 4 | Completed | Acute Stroke | 60 | China | clinicaltrials.gov |
| December 17, 2025 | NCT07289919 | Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils | University of Sao Paulo | Not applicable | Active not recruiting | Cardiovascular (CV) Risk, Atheroscleroses, Inflamation, Omega 3 Fatty Acids, Supplement | 15 | Brazil | clinicaltrials.gov |
| December 11, 2025 | NCT07276282 | Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction | ECRI bv | Phase 3 | Recruiting | Coronary Artery Disease, Acute Myocardial Infarction (AMI), Coronary Atherosclerosis of Native Coronary Artery | 332 | Switzerland | clinicaltrials.gov |
| December 5, 2025 | NCT07266220 | Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients. | Abdallah Ali Mohammed | Observational | Not yet recruiting | Diabetes Mellitus, Type 2, Chronic Kidney Disease, Atherosclerosis | 96 | clinicaltrials.gov | |
| December 4, 2025 | NCT07263113 | Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk... | Nantes University Hospital | Not applicable | Recruiting | Periodontis, Atherosclerosis Cardiovascular Disease | 206 | France | clinicaltrials.gov |
| November 19, 2025 | NCT07235046 | A Study of DII235 in Adults With Elevated Lipoprotein(a) | Novartis Pharmaceuticals | Phase 2 | Active not recruiting | Lipoprotein Disorder | 234 | China, Germany, Japan, United States | clinicaltrials.gov |
| November 10, 2025 | NCT07226193 | Detecting Peripheral Artery Disease With the Pulse | University of Nebraska | Not applicable | Recruiting | Peripheral Artery Disease (PAD) | 60 | United States | clinicaltrials.gov |
| October 23, 2025 | NCT07220304 | CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) | Corazon Medical PC | Not applicable | Not yet recruiting | Coronary Artery Disease, Atherosclerosis, Cardiovascular Inflammation | 15,000 | United States | clinicaltrials.gov |
| October 6, 2025 | NCT07208331 | Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Observational | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Hypertension, Dyslipidemia | 750 | Netherlands | clinicaltrials.gov |
| October 2, 2025 | NCT07203677 | Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT) | Brigham and Women's Hospital | Observational | Completed | Type2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease | 49,065 | United States | clinicaltrials.gov |
| October 1, 2025 | NCT07200804 | Relationship Between Serum Vitamin D and Atherosclerosis in Hemodialysis Patients | Ain Shams University | Observational | Completed | Serum, Vitamin D, Atherosclerosis, Hemodialysis | 90 | Egypt | clinicaltrials.gov |
| September 29, 2025 | NCT07196280 | Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK... | Chinese PLA General Hospital | Observational | Completed | Atherosclerotic Cardiovascular Disease (ASCVD), Benign Prostatic Hypertrophy (BPH) | 10,000 | clinicaltrials.gov | |
| September 17, 2025 | NCT07178015 | A Cohort Study on Cardiovascular and Cerebrovascular Outcomes | Sun Yat-sen University | Observational | Enrolling by invitation | Stroke, Atheroscleroses | 855 | China | clinicaltrials.gov |
| September 12, 2025 | NCT07169682 | Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis | National and Kapodistrian University of Athens | Observational | Completed | Psoriasis, Cardiovascular Disease, Atherosclerosis | 66 | Greece | clinicaltrials.gov |
| September 8, 2025 | NCT07160829 | Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management | Novo Nordisk A/S | Observational | Completed | Atherosclerotic Cardiovascular Disease, Heart Failure, Chronic Kidney Disease | 608 | Australia, India, South Korea, Thailand | clinicaltrials.gov |
| September 5, 2025 | NCT07157774 | Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) | Eli Lilly and Company | Phase 3 | Recruiting | Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD) | 10,450 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia... | clinicaltrials.gov |
| August 26, 2025 | NCT07141914 | A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real... | Novo Nordisk A/S | Observational | Completed | Overweight, Obesity, Heart Failure (HF), Atherosclerotic Cardiovascular Disease (ASCVD), Primary Prevention | 285,327 | United States | clinicaltrials.gov |
| August 21, 2025 | NCT07134166 | Cardiac Imaging in Systemic Disorders: the ORACLES Registry | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Lupus | 1,500 | clinicaltrials.gov | |
| August 14, 2025 | NCT07123610 | Mediterranean Diet Education in Shift Nurses: Effects on Sleep, Activity, and Health Parameters | Bahçeşehir University | Not applicable | Completed | Cardiovascular Diseases, Obesity Prevention, Atheroscleroses, Hypertension, Type 2 Diabetes Mellitus (T2DM)... | 130 | Turkey (Türkiye) | clinicaltrials.gov |
| August 13, 2025 | NCT07121010 | How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses | University of Pittsburgh | Not applicable | Recruiting | Cardiometabolic Health | 20 | United States | clinicaltrials.gov |
| August 6, 2025 | NCT07107971 | Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Recruiting | Coronary Artery Disease, Atheroscleroses, Cardiovascular Disease, Vulnerable Coronary Plaques, Vulnerable Plaque... | 400 | Netherlands | clinicaltrials.gov |
| August 5, 2025 | NCT07104487 | [18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease | Universitaire Ziekenhuizen KU Leuven | Phase 2 | Recruiting | Stroke (CVA) or TIA, Carotid Artery Plaque, Atherosclerosis Cardiovascular Disease, Carotid Arteriosclerosis | 24 | Belgium | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Novartis Pharmaceuticals | 9 | April 22, 2026 |
| Sanofi | 4 | October 30, 2026 |
| AstraZeneca | 4 | June 2, 2025 |
| Eli Lilly and Company | 3 | August 25, 2026 |
| Novo Nordisk A/S | 3 | September 8, 2025 |
| Washington University School of Medicine | 2 | November 4, 2026 |
| Assiut University | 2 | August 19, 2026 |
| Beijing Inno Medicine Co., Ltd. | 2 | April 9, 2026 |
| Liverpool John Moores University | 2 | March 16, 2026 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 2 | March 3, 2026 |
| Assistance Publique - Hôpitaux de Paris | 2 | February 23, 2026 |
| Université Catholique de Louvain | 2 | February 3, 2026 |
| Brigham and Women's Hospital | 2 | January 5, 2026 |
| University Hospital, Akershus | 2 | December 24, 2025 |
| University of Sao Paulo | 2 | December 17, 2025 |
| Nantes University Hospital | 2 | December 4, 2025 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 | October 6, 2025 |
| University of Florida | 2 | March 3, 2025 |
| Sir Run Run Shaw Hospital | 1 | November 5, 2026 |
| NYU Langone Health | 1 | November 4, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Observational | 59 | November 4, 2026 |
| Not applicable | 39 | November 5, 2026 |
| Phase 2 | 13 | September 24, 2026 |
| Phase 3 | 11 | September 2, 2026 |
| Phase 4 | 9 | September 24, 2026 |
| Early phase 1 | 3 | September 2, 2026 |
| Phase 1 | 3 | June 2, 2026 |
| Phase 1/2 | 2 | March 25, 2026 |
By country
| Country | New trials | Latest |
|---|---|---|
| United States | 33 | November 4, 2026 |
| China | 23 | November 5, 2026 |
| Spain | 14 | October 29, 2026 |
| Netherlands | 14 | October 29, 2026 |
| France | 12 | August 14, 2026 |
| United Kingdom | 11 | November 3, 2026 |
| Italy | 9 | October 30, 2026 |
| Australia | 8 | May 29, 2026 |
| Brazil | 8 | December 17, 2025 |
| Japan | 7 | August 25, 2026 |
| Hungary | 7 | August 3, 2026 |
| South Korea | 7 | July 22, 2026 |
| Germany | 7 | November 19, 2025 |
| Puerto Rico | 6 | August 25, 2026 |
| Czechia | 6 | May 29, 2026 |
| Canada | 6 | April 9, 2026 |
| Argentina | 5 | August 25, 2026 |
| Turkey (Türkiye) | 5 | March 3, 2026 |
| Belgium | 5 | February 3, 2026 |
| Greece | 5 | September 12, 2025 |
| Taiwan | 5 | September 5, 2025 |
| Mexico | 4 | October 2, 2026 |
| Austria | 4 | September 30, 2026 |
| Sweden | 4 | May 7, 2026 |
| India | 4 | September 8, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.